Placing on the market of genetically modified micro-organisms and the processing of organs
In interinstitutional negotiations (trilogues). Parliament and Council are working toward a provisional agreement, which would still need formal adoption to become law.
Last active 18 Nov 2026
AI system. Responses may contain errors. Why this matters
What this bill does
In plain terms: what it changes and who it affects.
This bill updates EU rules for genetically modified micro-organisms and processed transplant organs to support innovation while maintaining health and safety oversight.
It affects biotechnology businesses developing genetically modified micro-organisms and patients needing organ transplants. It also affects transplant centres using technologies to preserve or improve organs before transplantation.
- Creates specific EU rules for placing genetically modified micro-organisms on the market as or in products.
- Allows unlimited-duration consents for genetically modified micro-organisms, subject to safeguards if new risks emerge.
- Introduces low-risk genetically modified micro-organisms with adapted risk assessment, faster procedures and possible no monitoring plan.
- Requires prior authority authorisation before transplant centres apply processed organs to recipients.
- Takes effect
- The Directive enters into force on the twentieth day following publication in the Official Journal of the European Union.
- Transitional law
- Member States must transpose the Directive within 24 months from its entry into force.
- Directive 2001/18/EC (32001L0018)
- art. 2: adds definitions for micro-organism, GMM and Qualified Presumption of Safety
- art. Part C: inserts Title I heading for general provisions applicable to GMOs as or in products
- art. 24a: inserts specific rules on subject matter and status of GMMs
- art. 24b: inserts power to adapt information requirements for GMM notifications
- art. 24c: inserts unlimited validity rule for GMM consents
- art. 24d: inserts adapted rules for GMM detection methods
- art. 24e: inserts low-risk GMM criteria and delegated powers
- art. 24f: inserts monitoring and reporting rules for low-risk GMMs
- art. 24g: inserts implementing act powers for detection modalities and low-risk supporting information
- art. 29a: replaces Article 29a on exercise of delegation
- Directive 2010/53/EU (32010L0053)
- art. 2(1): replaces scope provision to include processing of organs
- art. 3(q): replaces definition of transplantation
- art. 3(ka): inserts definition of processing
- art. 6a: inserts organ processing authorisation and oversight regime
- art. Annex Part B: adds Processing entry to complementary organ and donor characterisation data
Latest update
20 Nov 2026The most recent development in this bill's progress.
Trilogues (interinstitutional negotiations) → Trilogues (interinstitutional negotiations)
Trilogues (interinstitutional negotiations) → Trilogues (interinstitutional negotiations)
Documents
1 recentSourcesOEILEUR-LexEU Law Tracker